How one OD uses Oxervate for corneal healing

There is treatment hope for neurotrophic keratitis, a rare disease affecting the cornea.

Scott Schachter, OD, reviews Oxervate, the first FDA-approved treatment for neurotrophic keratitis to exhibit complete corneal healing.

Related Videos
Related Content

This week in optometry: March 20-March 24

March 25th 2023

Practical management EP 9: Understanding the difference between branding & marketing

March 24th 2023

My practice journey

March 15th 2023

Practical management EP 8: First steps to increase net revenue

March 16th 2023

This week in optometry: February 25-March 2

March 3rd 2023

Diversity, equity, inclusion, and belonging—in practice

February 28th 2023

This week in optometry: March 20-March 24

March 25th 2023

Practical management EP 9: Understanding the difference between branding & marketing

March 24th 2023

My practice journey

March 15th 2023

Practical management EP 8: First steps to increase net revenue

March 16th 2023

This week in optometry: February 25-March 2

March 3rd 2023

Diversity, equity, inclusion, and belonging—in practice

February 28th 2023

This week in optometry: March 20-March 24

March 25th 2023

Practical management EP 9: Understanding the difference between branding & marketing

March 24th 2023

My practice journey

March 15th 2023

Practical management EP 8: First steps to increase net revenue

March 16th 2023

This week in optometry: February 25-March 2

March 3rd 2023

Diversity, equity, inclusion, and belonging—in practice

February 28th 2023
© 2023 MJH Life Sciences

All rights reserved.